Every 5 years, the JAS publishes guidelines for the treatment of dyslipidemia and
atherosclerosis. To date, this society has released four such guidelines. Since 2007, the JAS …

In Japan, a consensus conference on hyperlipidemia was held in 1987, and diagnostic
criteria for hyperlipidemia were proposed. They were based on a consensus of experts and …

In Japan, a super-aged society, deaths from atherosclerotic cardiovascular disease
(ASCVD), especially cardiac diseases including coronary artery disease (CAD) such as …

To prevent CVD, it is important to manage dyslipidemia in addition to other risk factors. For
this purpose, we propose comprehensive risk management for the prevention of CVD. Risk …

Atherosclerotic cardiovascular disease is the most important public health problem of our
time in both Europe and the rest of the world, accounting for the greatest expenditure in most …

Cardiovascular disease (CVD) is becoming more prevalent worldwide and is one of the
leading causes of death. 1 To lower CVD mortality, aggressive and comprehensive …

Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of death among urban
and rural residents in China, and elevated low-density lipoprotein cholesterol (LDL-C) is a …

Atherosclerotic cardiovascular (CV) disease (ASCVD) incidence and mortality rates are
declining in many countries in Europe, but it is still a major cause of morbidity and mortality …

2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment
of dyslipidemia and prevention of cardi Page 1 Can J Cardiol Vol 25 No 10 October 2009 567 …

Cardiovascular disease (CVD) is a growing burden across the world. In Asia and the Middle
East, in particular, CVD is among the most prevalent and debilitating diseases. Dyslipidemia …